info@seagull-health.com
SeagullHealth
语言:
search

Koselugo(Selumetinib) Side Effects

KOSELUGO is associated with a high incidence of gastrointestinal, dermatologic, and musculoskeletal adverse reactions.

Adverse Reaction Profile of KOSELUGO


The most common side effects of KOSELUGO include vomiting, rash, abdominal pain, diarrhea, nausea, dry skin, fatigue, musculoskeletal pain, fever, acneiform rash, stomatitis, headache, paronychia, and pruritus, with many occurring in over 40% of patients. Serious adverse events such as cardiomyopathy, ocular toxicity, increased creatine phosphokinase, and risk of bleeding have also been reported. Laboratory abnormalities include elevated creatine phosphokinase, liver enzymes, and decreased blood counts. Permanent discontinuation due to adverse reactions occurred in 12% of patients. Long-term safety data and effects in populations outside the studied group are not specified in the description.

Selumetinib(Koselugo)
Selumetinib(Koselugo)
KOSELUGO (selumetinib) is indicated for the treatment of pediatric patients...
WeChat Scan
Free Inquiry
Related articles
Adverse reactions caused by Selumetinib bisulfate capsules
The U.S. FDA Approved Selumetinib (Koselugo) for the Treatment of Pediatric Patients 2 years of age and older with Neurofibromatosis Type 1 (NF1) and Symptomatic, Inoperable Plexiform Neurofibromas (P...
Selumetinib side effects
Selumetinib is a targeted drug for the treatment of neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas, which may also bring a series of side effects. Mastering the correct mitigat...
Adverse effects of Selumetinib
As a highly effective tyrosine kinase inhibitor, Selumetinib has shown significant anti-lesion effect in clinical treatment, bringing new hope to many patients with lesions. As with many potent d...
共 3 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved